Inebilizumab Biosimilar - Anti-CD19 Antibody - BSA and Azide free (A318906)

Inebilizumab Biosimilar - Anti-CD19 Antibody - BSA and Azide free

Recombinant humanized monoclonal antibody to CD19.

ELISA, Flow Cytometry

ELISA: 1:5,000-10,000, Flow Cytometry: 1:100

Human

Humanized

Monoclonal

IgG1

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B4, CD19 antigen, CD19 molecule, Cd19 protein, CD19_HUMAN, CVID3, Differentiation antigen CD19, Leu 12, Leu-12, Leu12, MGC109570, MGC12802, T-cell surface antigen Leu-12